IHC Marker - Beta HCG Test
About IHC Marker - Beta HCG Test
| Field | Value |
|---|---|
| Also Known As | Beta HCG IHC, β-hCG IHC, Human Chorionic Gonadotropin IHC, hCG IHC Marker |
| Sample Type | Tissue sample (formalin-fixed paraffin-embedded biopsy or surgical specimen) |
| Fasting Required | No |
| Report Time | 3 Days |
| Recommended For | Males and females of all ages suspected of germ cell tumours or trophoblastic disease |
| Price | Starting at ₹1,920 |
What is an IHC Marker - Beta HCG Test?
The IHC marker - Beta HCG test is a specialised laboratory examination that detects the presence of beta-human chorionic gonadotropin (β-hCG) protein within tissue samples. A pathologist uses specific antibodies to identify this protein in cells examined under a microscope.
The test is typically ordered when a doctor suspects germ cell tumours, trophoblastic disease, or certain other cancers. It is also known as the Beta HCG IHC or hCG IHC marker test.
What Does an IHC Marker - Beta HCG Test Measure?
The IHC marker - Beta HCG test procedure analyses tissue at a cellular level to identify β-hCG protein expression. The table below summarises what the test evaluates.
| Parameter | What it Shows |
|---|---|
| β-hCG IHC staining | Whether β-hCG protein is present (positive) or absent (negative) in the tissue |
| Staining intensity | Scored on a 4-point scale: 0 (negative), 1 (weak), 2 (moderate), 3 (strong) |
| Extent of staining | Percentage of cells showing positive staining: 0 to 25% (+), 26 to 50% (++), 51 to 75% (+++), 76 to 100% (++++) |
The test produces a qualitative result rather than a numerical value. The pathologist describes the staining pattern, intensity, and distribution to help reach a diagnosis.
Why is an IHC Marker - Beta HCG Test Done?
Doctors order this test when tissue analysis is needed to identify or classify certain tumours. Below are the most common reasons it is requested.
Common Symptoms That May Require This Test
The following symptoms may prompt a doctor to request this test:
- Pain or swelling in the testicles, ovaries, or abdomen
- An unexplained testicular or pelvic mass
- Abnormal uterine bleeding without a clear cause
- A biopsy result showing unusual or unclassified cell types
- Suspected spread (metastasis) of a tumour from an unknown primary site
- Abnormal findings on imaging, such as an ultrasound or CT scan
Conditions This Test Can Help Detect
This test can assist in identifying the following conditions:
- Choriocarcinoma (a fast-growing tumour of trophoblastic cells)
- Seminomatous and non-seminomatous testicular germ cell tumours
- Ovarian germ cell tumours
- Gestational trophoblastic disease, including hydatidiform mole
- Mixed germ cell tumours with a syncytiotrophoblastic component
- Certain carcinomas of the lung, breast, and gastrointestinal tract that produce β-hCG
IHC Marker - Beta HCG Test for Chronic Disease Monitoring
This test has a role in monitoring patients who have already been treated for β-hCG-producing tumours. If β-hCG staining reappears on a subsequent biopsy, it may indicate that the tumour has returned.
Pathologists also use the test after surgery to check for residual disease and to assess how well treatment is working.
How to Prepare and What to Expect
This test is performed on a tissue sample obtained through biopsy or surgery, not through a routine blood draw. Here is what you need to know before the test.
Do You Need to Fast?
No fasting is required. The test is carried out on a tissue block submitted to the laboratory, so food and drink intake does not affect the result.
Practical Tips Before Your Test
Keep the following in mind before your appointment:
- Bring a detailed clinical history, including your symptoms, previous test results, and relevant medical records, as this is required for the test.
- Carry a valid prescription from your doctor, as it is needed to proceed with the test.
- Inform your doctor about any medications you are currently taking.
- Ensure the biopsy specimen or tissue block is transported in the correct container and at the correct temperature as directed by the laboratory.
Step-by-Step Procedure
The IHC marker - Beta HCG test procedure involves the following steps:
- A doctor collects a tissue sample through a biopsy (needle, incisional, or excisional) or during a surgical procedure.
- The tissue is fixed in formalin and then processed and embedded in a paraffin block, creating what is called an FFPE (formalin-fixed paraffin-embedded) tissue block.
- The block is submitted to the Lupin Diagnostics laboratory, where thin sections are cut from it.
- Laboratory technologists apply a specific β-hCG antibody to the tissue sections. This antibody binds to β-hCG protein wherever it is present in the cells.
- A secondary antibody and detection reagent are added, producing a visible colour change at sites where β-hCG is expressed.
- A qualified pathologist examines the stained slides under a microscope and issues a detailed report.
Factors That Can Affect Accuracy
The following factors can affect the quality of the test result:
- Poor tissue fixation (too short or too long in formalin)
- Delays in processing the tissue after collection
- Inadequate antigen retrieval during laboratory processing
- Sampling error if the tumour contains mixed cell types
- Antibody specificity and the technique used in the laboratory
Understanding Your IHC Marker - Beta HCG Test Results
Results from this test are qualitative and must be reviewed by a qualified pathologist and your treating doctor. The table below describes what the findings generally indicate.
| Finding | What it May Suggest |
|---|---|
| Positive staining (any intensity)/Reactive | β-hCG protein is present in the tissue; may indicate choriocarcinoma, germ cell tumour, or trophoblastic disease |
| Negative staining/Non-reactive | β-hCG protein is not detected; the tumour may not express this marker, or a different cell type may be present |
| Focal or weak positivity | Limited expression; pathologist will assess in context with clinical findings and other markers |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
Pregnancy and certain inflammatory conditions can also cause cells to produce β-hCG.
A positive result on this test does not automatically confirm a tumour, and your doctor will consider your full clinical picture before concluding.
In addition, over-fixation of the tissue block can affect staining quality, which is why correct specimen handling is important.
How to Maintain Healthy Levels
The following general wellness measures are worth keeping in mind:
- Attend regular health check-ups as recommended by your doctor, particularly if you have known risk factors for germ cell tumours.
- Males should practise monthly testicular(balls/sac-like male reproductive organs) self-examination to detect any unusual lumps or changes early.
- Keep all follow-up appointments with your specialist after any tumour treatment.
Lupin Diagnostics IHC Marker - Beta HCG Test Price
The IHC marker - Beta HCG test cost at Lupin Diagnostics starts at ₹1,920. This test requires a visit to a Lupin Diagnostics centre or the submission of a prepared tissue block; home collection is not available for this test.
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 1920 |
| CHENNAI | 1920 |
| HYDERABAD | 1920 |
| KOLKATA | 1920 |
| NAVI MUMBAI | 1920 |
| PUNE | 1920 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
You can book the IHC marker - Beta HCG test online through the following steps:
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred centre location.
- Visit the centre at your scheduled time to submit your tissue block or biopsy specimen along with the required clinical history and prescription.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
A regular Beta HCG blood test measures the level of the hormone in your blood and is mainly used to confirm pregnancy or monitor certain tumour markers quantitatively. The IHC marker - Beta HCG test examines a tissue sample under a microscope to detect the protein inside cells, and is used specifically for cancer diagnosis and classification by a pathologist.
A doctor orders this test to confirm whether a tumour is producing β-hCG protein and to help classify the type of cancer present. It is commonly requested when a pathologist needs to confirm choriocarcinoma or identify the β-hCG-producing component within a germ cell tumour.
No. The IHC marker - Beta HCG test home collection is not available because this test requires a tissue sample obtained through biopsy or surgery in a clinical setting. The tissue block must then be submitted directly to the laboratory.
At Lupin Diagnostics, the report is typically delivered within 3 days of the laboratory receiving the tissue sample. Turnaround time can vary depending on the complexity of the case.
No. The IHC marker - Beta HCG test is specifically designed to identify tumours that produce β-hCG, such as germ cell tumours and trophoblastic disease. Other cancer types require different IHC markers, and a panel of tests is often used together.
A negative result means the tested tissue does not express the β-hCG marker. It does not exclude cancer entirely, as some tumours do not produce this protein. Your doctor may order additional markers or investigations to complete the assessment.
Yes. You must bring a valid doctor's prescription and a detailed clinical history, including your symptoms, prior test results, and any relevant medical records. This information is required for the test to be processed accurately.
IHC Marker - Beta HCG Test
